Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest announcement is out from Hansoh Pharmaceutical Group Company Limited ( (HK:3692) ).
Hansoh Pharmaceutical Group Company Limited announced the placement of 108,000,000 new shares under a general mandate, with the shares priced at HK$36.30 each. This placement is expected to generate gross proceeds of approximately HK$3,920.40 million, which will be used for purposes detailed in the company’s announcement. The placement represents about 1.82% of the company’s total shares in issue and is subject to certain conditions and approvals. The move is part of the company’s strategy to strengthen its financial position and support its operational goals.
The most recent analyst rating on (HK:3692) stock is a Buy with a HK$39.93 price target. To see the full list of analyst forecasts on Hansoh Pharmaceutical Group Company Limited stock, see the HK:3692 Stock Forecast page.
More about Hansoh Pharmaceutical Group Company Limited
Hansoh Pharmaceutical Group Company Limited is a pharmaceutical company incorporated in the Cayman Islands, focusing on the development, manufacture, and sale of pharmaceutical products. The company operates in the healthcare industry, providing a range of medications and treatments.
Average Trading Volume: 11,558,322
Technical Sentiment Signal: Buy
Current Market Cap: HK$221.8B
Find detailed analytics on 3692 stock on TipRanks’ Stock Analysis page.